Real-time enrollment status for this meningiomas clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:09 PM UTC
| NCT Number | NCT02523014 |
| Recruiting Status | Recruiting |
| Condition | Meningiomas |
| Phase | PHASE2 |
| Target Enrollment | 124 participants |
| Active Locations | 780 sites in the US |
| Sponsor | Alliance for Clinical Trials in Oncology |
| Last Updated on CT.gov | July 2, 2026 (2 weeks ago) |
As of July 18, 2026: Clinical trial NCT02523014 is currently recruiting participants. This phase2 study for meningiomas is actively seeking new participants at 780 locations across the United States. The study is sponsored by Alliance for Clinical Trials in Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02523014 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 780 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02523014 was last updated 2 weeks ago (July 2, 2026). HelloStudys verifies this status automatically.